Total hepatectomy, recombinant activated factor VII and rescue liver transplantation

P. Cozzi, D. Chiumello, D. Tubiolo, A. Sicignano, G. Brandi, P. Bianchi, S. Coppola, M. L. Caspani, G. Rossi

Research output: Contribution to journalArticle

Abstract

The aim of this paper was to describe a case of acute liver failure treated with total hepatectomy, recombinant activated factor VII and rescue liver transplantation. We reported our experience with a 51-year-old-woman who developed a massive portal thrombosis after cadaveric liver transplantation for hepatic epithelioid hemangioendothelioma and who then required a total hepatectomy and porto-caval shunt as a bridge procedure while waiting for an urgent new liver transplantation. Subsequently, the patient developed severe hemodynamic instability, massive abdominal and mucosal bleeding and acute renal failure that were managed with infusion of high doses of inotropes, red blood cells and fresh frozen plasma as well as continuous veno-venous hemofiltration. Due to persistent, uncontrolled bleeding, we considered the off-label use of rFVIIa. This caused a correction of the prothrombin times and allowed for sufficient hemostasis. The patient received a new cadaveric liver that was reperfused 38 hours after the first graft was removed. The transplanted liver showed immediate recovery, the hemodynamics ameliorated and the patient was fully awake at day five. In the case of an anhepatic phase complicated by severe bleeding that is unresponsiveness to several transfusions, a single administration of rFVIIa should be considered as a rescue therapy to control massive bleeding.

Original languageEnglish
Pages (from-to)550-553
Number of pages4
JournalMinerva Anestesiologica
Volume76
Issue number7
Publication statusPublished - Jul 2010

Fingerprint

Factor VIIa
Hepatectomy
Liver Transplantation
Hemorrhage
Liver
Hemodynamics
Epithelioid Hemangioendothelioma
Off-Label Use
Hemofiltration
Venae Cavae
Acute Liver Failure
Prothrombin Time
Hemostasis
Acute Kidney Injury
Thrombosis
Erythrocytes
Transplants
recombinant FVIIa
Therapeutics

Keywords

  • Factor VII
  • Hepatectomy
  • Liver transplantation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Total hepatectomy, recombinant activated factor VII and rescue liver transplantation. / Cozzi, P.; Chiumello, D.; Tubiolo, D.; Sicignano, A.; Brandi, G.; Bianchi, P.; Coppola, S.; Caspani, M. L.; Rossi, G.

In: Minerva Anestesiologica, Vol. 76, No. 7, 07.2010, p. 550-553.

Research output: Contribution to journalArticle

Cozzi, P, Chiumello, D, Tubiolo, D, Sicignano, A, Brandi, G, Bianchi, P, Coppola, S, Caspani, ML & Rossi, G 2010, 'Total hepatectomy, recombinant activated factor VII and rescue liver transplantation', Minerva Anestesiologica, vol. 76, no. 7, pp. 550-553.
Cozzi P, Chiumello D, Tubiolo D, Sicignano A, Brandi G, Bianchi P et al. Total hepatectomy, recombinant activated factor VII and rescue liver transplantation. Minerva Anestesiologica. 2010 Jul;76(7):550-553.
Cozzi, P. ; Chiumello, D. ; Tubiolo, D. ; Sicignano, A. ; Brandi, G. ; Bianchi, P. ; Coppola, S. ; Caspani, M. L. ; Rossi, G. / Total hepatectomy, recombinant activated factor VII and rescue liver transplantation. In: Minerva Anestesiologica. 2010 ; Vol. 76, No. 7. pp. 550-553.
@article{521dd4b6e50c4cd9bf2234b41d0e3c44,
title = "Total hepatectomy, recombinant activated factor VII and rescue liver transplantation",
abstract = "The aim of this paper was to describe a case of acute liver failure treated with total hepatectomy, recombinant activated factor VII and rescue liver transplantation. We reported our experience with a 51-year-old-woman who developed a massive portal thrombosis after cadaveric liver transplantation for hepatic epithelioid hemangioendothelioma and who then required a total hepatectomy and porto-caval shunt as a bridge procedure while waiting for an urgent new liver transplantation. Subsequently, the patient developed severe hemodynamic instability, massive abdominal and mucosal bleeding and acute renal failure that were managed with infusion of high doses of inotropes, red blood cells and fresh frozen plasma as well as continuous veno-venous hemofiltration. Due to persistent, uncontrolled bleeding, we considered the off-label use of rFVIIa. This caused a correction of the prothrombin times and allowed for sufficient hemostasis. The patient received a new cadaveric liver that was reperfused 38 hours after the first graft was removed. The transplanted liver showed immediate recovery, the hemodynamics ameliorated and the patient was fully awake at day five. In the case of an anhepatic phase complicated by severe bleeding that is unresponsiveness to several transfusions, a single administration of rFVIIa should be considered as a rescue therapy to control massive bleeding.",
keywords = "Factor VII, Hepatectomy, Liver transplantation",
author = "P. Cozzi and D. Chiumello and D. Tubiolo and A. Sicignano and G. Brandi and P. Bianchi and S. Coppola and Caspani, {M. L.} and G. Rossi",
year = "2010",
month = "7",
language = "English",
volume = "76",
pages = "550--553",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "7",

}

TY - JOUR

T1 - Total hepatectomy, recombinant activated factor VII and rescue liver transplantation

AU - Cozzi, P.

AU - Chiumello, D.

AU - Tubiolo, D.

AU - Sicignano, A.

AU - Brandi, G.

AU - Bianchi, P.

AU - Coppola, S.

AU - Caspani, M. L.

AU - Rossi, G.

PY - 2010/7

Y1 - 2010/7

N2 - The aim of this paper was to describe a case of acute liver failure treated with total hepatectomy, recombinant activated factor VII and rescue liver transplantation. We reported our experience with a 51-year-old-woman who developed a massive portal thrombosis after cadaveric liver transplantation for hepatic epithelioid hemangioendothelioma and who then required a total hepatectomy and porto-caval shunt as a bridge procedure while waiting for an urgent new liver transplantation. Subsequently, the patient developed severe hemodynamic instability, massive abdominal and mucosal bleeding and acute renal failure that were managed with infusion of high doses of inotropes, red blood cells and fresh frozen plasma as well as continuous veno-venous hemofiltration. Due to persistent, uncontrolled bleeding, we considered the off-label use of rFVIIa. This caused a correction of the prothrombin times and allowed for sufficient hemostasis. The patient received a new cadaveric liver that was reperfused 38 hours after the first graft was removed. The transplanted liver showed immediate recovery, the hemodynamics ameliorated and the patient was fully awake at day five. In the case of an anhepatic phase complicated by severe bleeding that is unresponsiveness to several transfusions, a single administration of rFVIIa should be considered as a rescue therapy to control massive bleeding.

AB - The aim of this paper was to describe a case of acute liver failure treated with total hepatectomy, recombinant activated factor VII and rescue liver transplantation. We reported our experience with a 51-year-old-woman who developed a massive portal thrombosis after cadaveric liver transplantation for hepatic epithelioid hemangioendothelioma and who then required a total hepatectomy and porto-caval shunt as a bridge procedure while waiting for an urgent new liver transplantation. Subsequently, the patient developed severe hemodynamic instability, massive abdominal and mucosal bleeding and acute renal failure that were managed with infusion of high doses of inotropes, red blood cells and fresh frozen plasma as well as continuous veno-venous hemofiltration. Due to persistent, uncontrolled bleeding, we considered the off-label use of rFVIIa. This caused a correction of the prothrombin times and allowed for sufficient hemostasis. The patient received a new cadaveric liver that was reperfused 38 hours after the first graft was removed. The transplanted liver showed immediate recovery, the hemodynamics ameliorated and the patient was fully awake at day five. In the case of an anhepatic phase complicated by severe bleeding that is unresponsiveness to several transfusions, a single administration of rFVIIa should be considered as a rescue therapy to control massive bleeding.

KW - Factor VII

KW - Hepatectomy

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=77954976007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954976007&partnerID=8YFLogxK

M3 - Article

C2 - 20613697

AN - SCOPUS:77954976007

VL - 76

SP - 550

EP - 553

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 7

ER -